AGC Inc. (ASGLY)

Achilles Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,443	6,245	7,867	7,387	10,581	7,730
Market Cap Growth	-16.89%	-20.62%	6.49%	-30.18%	36.87%	-3.52%
Enterprise Value	11,769	11,075	13,401	12,072	15,952	15,905
Last Close Price	6.16	5.95	7.37	6.51	9.62	6.95
PE Ratio	-	-	16.85	-	9.84	24.39
PS Ratio	0.47	0.48	0.55	0.48	0.72	0.56
PB Ratio	0.61	0.59	0.67	0.61	0.82	0.64
P/TBV Ratio	0.76	0.74	0.87	0.79	1.08	0.86
P/FCF Ratio	47.50	23.13	-	-	10.49	23.52
P/OCF Ratio	3.68	3.45	5.22	4.49	3.73	3.54
EV/Sales Ratio	0.85	0.84	0.94	0.78	1.08	1.16
EV/EBITDA Ratio	5.70	5.81	6.17	4.31	4.95	7.54
EV/EBIT Ratio	13.75	14.68	14.46	8.68	9.00	22.16
EV/FCF Ratio	86.77	41.01	-	-	15.81	48.39
Debt / Equity Ratio	0.42	0.39	0.42	0.41	0.41	0.63
Debt / EBITDA Ratio	2.18	2.17	2.27	1.76	1.63	3.62
Debt / FCF Ratio	32.77	15.30	-	-	5.19	23.23
Asset Turnover	0.72	0.71	0.70	0.74	0.65	0.58
Inventory Turnover	3.50	3.45	3.45	3.93	3.92	3.72
Quick Ratio	0.69	0.68	0.73	0.82	0.85	0.93
Current Ratio	1.36	1.43	1.45	1.59	1.53	1.53
Return on Equity (ROE)	-3.16%	-4.69%	5.09%	1.47%	11.68%	3.26%
Return on Assets (ROA)	2.70%	2.55%	2.84%	4.18%	4.90%	1.90%
Return on Capital (ROIC)	3.36%	3.17%	3.56%	5.31%	6.20%	2.36%
Return on Capital Employed (ROCE)	6.00%	5.40%	5.90%	8.60%	9.90%	3.80%
Earnings Yield	-6.89%	-9.58%	5.93%	-0.32%	10.17%	4.10%
FCF Yield	2.11%	4.32%	-0.09%	-0.69%	9.53%	4.25%
Dividend Yield	22.60%	22.45%	20.21%	24.46%	14.45%	16.73%
Payout Ratio	-	-	69.88%	-	25.07%	81.28%
Buyback Yield / Dilution	0.97%	2.08%	2.35%	0.29%	-0.05%	0.01%
Total Shareholder Return	24.35%	24.52%	22.56%	24.75%	14.41%	16.74%

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.